Zacks Investment Research on MSN
Here is what to know beyond why Hims & Hers Health, Inc. (HIMS) is a trending stock
Hims & Hers Health, Inc. (HIMS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...
Shares of Hims & Hers Health Inc HIMS are trading higher Wednesday morning, fueled by a wave of investor confidence following ...
Hims & Hers built massive weight-loss markets using telehealth. Peptides, if authorized by the FDA, stand to become a major ...
Hims & Hers Health's revenue grew 59% to $2.35B in 2025, while adjusted EBITDA surged nearly 80% to $318M. Operating cash flow reached $300M, with $929M in liquidity, reinforcing balance sheet ...
Few people consult a doctor before attempting weight loss. Hims offers virtual weight loss support for men, including consultations and prescriptions. Hims provides GLP-1 injections, meal replacements ...
NEW YORK, March 2 (Reuters) - Telehealth company Hims & Hers Health, known for its weight-loss drug business, is promising it can diversify away from its reliance on compounded GLP-1 sales in the U ...
Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting results this Monday after the bell. Here’s what to expect.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results